S
Stimdia Medical
Developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation
About Stimdia Medical
Stimdia Medical specializes in developing advanced medical devices aimed at aiding mechanically ventilated patients in weaning off ventilators. The company's flagship product, the pdSTIM System, employs a minimally invasive method to temporarily stimulate the phrenic nerve, facilitating diaphragmatic function and improving patient outcomes. Stimdia Medical primarily serves healthcare providers and hospitals, focusing on adult patients who have been on mechanical ventilation for extended periods and have failed weaning attempts. Operating in the medical device market, the company generates revenue through the sale of its pdSTIM System and related services. Stimdia Medical's business model includes direct sales and partnerships with healthcare institutions. The company is committed to innovation and has made significant advancements, including the initiation of pivotal clinical studies and strategic growth initiatives.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Bloomington, United States
- Employees
- 14
- Open positions
- None listed
- Dealroom signal
- 73.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Critical medical care, Respiratory, Neuromodulation and Neurostimulation, Spinout, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Stimdia Medical.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jul 2022 | $16M | $64M | Draper Triangle Ventures · Solas BioVentures | ↗ |
| EARLY VC✓Equity / VC | Dec 2019 | $1.9M | $7.6M | Undisclosed | — |
Growth signals
Latest recorded traffic for Stimdia Medical is 1.6K monthly website visits, up 90.5% over the last three months. Stimdia Medical's team declined 12.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Solas BioVentures
Draper Triangle Ventures
Other known investors3 additional known investors
University of Minnesota Twin Cities- DCDiscovery Capital
Magarac Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Stimdia Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Stimdia Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.